Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.53 HKD
−419.66 M HKD
272.24 M HKD
298.60 M
About OCUMENSION THERAPEUTICS
Ocumension Therapeutics engages in the identification, development, and commercialization of ophthalmic therapies. The company was founded in 2017 and is headquartered in Suzhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1477 is 4.67 HKD — it has decreased by −0.64% in the past 24 hours. Watch OCUMENSION THERAPEUTICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange OCUMENSION THERAPEUTICS stocks are traded under the ticker 1477.
1477 stock has fallen by −10.86% compared to the previous week, the month change is a −7.69% fall, over the last year OCUMENSION THERAPEUTICS has showed a −30.61% decrease.
We've gathered analysts' opinions on OCUMENSION THERAPEUTICS future price: according to them, 1477 price has a max estimate of 11.72 HKD and a min estimate of 11.72 HKD. Watch 1477 chart and read a more detailed OCUMENSION THERAPEUTICS stock forecast: see what analysts think of OCUMENSION THERAPEUTICS and suggest that you do with its stocks.
1477 reached its all-time high on Jul 10, 2020 with the price of 43.00 HKD, and its all-time low was 4.13 HKD and was reached on Sep 13, 2024. View more price dynamics on 1477 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1477 stock is 3.90% volatile and has beta coefficient of 1.21. Track OCUMENSION THERAPEUTICS stock price on the chart and check out the list of the most volatile stocks — is OCUMENSION THERAPEUTICS there?
Today OCUMENSION THERAPEUTICS has the market capitalization of 3.79 B, it has decreased by −2.55% over the last week.
Yes, you can track OCUMENSION THERAPEUTICS financials in yearly and quarterly reports right on TradingView.
OCUMENSION THERAPEUTICS is going to release the next earnings report on Mar 21, 2025. Keep track of upcoming events with our Earnings Calendar.
1477 earnings for the last half-year are −0.25 HKD per share, whereas the estimation was −0.23 HKD, resulting in a −9.52% surprise. The estimated earnings for the next half-year are −0.15 HKD per share. See more details about OCUMENSION THERAPEUTICS earnings.
OCUMENSION THERAPEUTICS revenue for the last half-year amounts to 180.10 M HKD, despite the estimated figure of 182.16 M HKD. In the next half-year revenue is expected to reach 335.17 M HKD.
1477 net income for the last half-year is −164.00 M HKD, while the previous report showed −185.15 M HKD of net income which accounts for 11.43% change. Track more OCUMENSION THERAPEUTICS financial stats to get the full picture.
No, 1477 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 444.00 employees. See our rating of the largest employees — is OCUMENSION THERAPEUTICS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OCUMENSION THERAPEUTICS EBITDA is −296.34 M HKD, and current EBITDA margin is −139.88%. See more stats in OCUMENSION THERAPEUTICS financial statements.
Like other stocks, 1477 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OCUMENSION THERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OCUMENSION THERAPEUTICS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OCUMENSION THERAPEUTICS stock shows the sell signal. See more of OCUMENSION THERAPEUTICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.